Bonesupport Holding AB

Price Chart

Risk-Adjusted Performance

Also Listed On

Bonesupport Holding AB (BONEX) Price Performance

Bonesupport Holding AB (BONEX) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at SEK269.00, up 0.37% from the previous close.

Over the past year, BONEX has traded between a low of SEK167.90 and a high of SEK340.00. The stock has lost 13.6% over this period. It is currently 20.9% below its 52-week high.

Bonesupport Holding AB has a market capitalization of $16.21B, with a price-to-earnings ratio of 116.13.

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Compare Bonesupport Holding AB

Side-by-side comparison against top Healthcare peers.